{"id":67737,"name":"TIBER CREEK GROUP ON BEHALF OF DAIICHI SANKYO, INC.","slug":"tiber-creek-group-on-behalf-of-daiichi-sankyo-inc","state":"DC","country":"United States of America","description":"Global pharmaceutical company.","totalSpending":90000,"filings":4,"yearlySpending":[{"year":2025,"income":90000}],"issues":["HCR","MMM","PHA"],"firms":["B HALL STRATEGIES, LLC"],"lobbyists":["JAMES HALL"],"govEntities":["SENATE"],"sampleDescriptions":["Issues related to drug pricing and reimbursement for prescription drugs; Issues related to orphan drugs.","Issues related to drug pricing in the One Big Beautiful Bill Act (PL 119-21).","Issues related to drug pricing. Public Law 119-21: One Big Beautiful Bill Act.","Issues related to drug pricing."],"years":[2025]}